Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2005
11/08/2005US6962999 Using a nickel or palladium catalyzed coupling in which the catalyst has at least one phosphine or phosphite ligand
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103020A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005US20050245762 Isolating chlorosuccinic acid by cooling to 10-20 degrees C. to effect precipitation, where the acid has been prepared by reacting a suspension of aspartic acid in demineralized water containing NaCl with NaNO2 and aqueous HCl; mother liquors from previous reactions may be used as partial substitutes
11/03/2005US20050245760 Preparing liquid-crystalline compounds, agrochemicals, pharmaceuticals or intermediates by providing stereoisomerically enriched 4-aryl-4-hydroxybutanoic acid derivatives
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245706 6-Trifluoromethyl-2 vinyloxy-4-oxatricyclo[4.2.1.03,7]noname-5-one, and polymer compound
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245573 N-substituted benzene sulfonamides
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050244718 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
11/03/2005DE102005012585A1 New dibenzofuran-, dibenzothiophene- and fluorene derivatives useful in liquid crystalline media, which is useful in e.g. electro optical display elements
11/03/2005CA2563615A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1590492A1 Tanning agents and preservatives
11/02/2005EP1590491A1 Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1523477B1 Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-l-gulonic acid
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1012147B1 O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
11/02/2005EP0930296B2 Fluorinated prostaglandin derivatives and medicines
11/02/2005CN1692130A Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation
11/02/2005CN1692119A Process for producing 2-deoxyaldose compound
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1691935A Ascorbic acid salt suspensions and use thereof as antioxidants
11/02/2005CN1690851A Chemical amplification positive photoresist compositions, (methyl) acrylate derivatives and method for preparing same
11/02/2005CN1690054A Vitamine C refining process
11/02/2005CN1225463C Arylated furane and thenoyl amine with potassium channel blocking effect
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960613 administering (S)-1-[3-(dimethyl-amino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile or a salt; selective, centrally acting serotonin reuptake inhibitor for panic attacks and obsessive compulsive disorders
11/01/2005US6960594 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/27/2005WO2005100505A1 New organic luminescent element
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100310A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005WO2005100309A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005099684A1 Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia
10/27/2005WO2005007103A3 Use of parthenolide derivatives as antileukemic and cytotoxic agents
10/27/2005US20050240060 Low loss high refractive index vinyl sulfide compounds and method of making same
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050240033 Hydrogenation catalyst, preparation thereof, and method for the preparation of gamma-butyrolactone from maleic anhydride using the catalyst
10/27/2005US20050240031 Oxidic catalyst for production of phthalic anhydride by oxidizing o-xylene, naphthalene, or mixtures thereof, which catalyst comprises from 2 to 15% by weight of vanadium, from 1 to 15% by weight of tin, from 70 to 97% by weight of titanium oxide and alkali metal oxides; high activity, high selectivity
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050238973 Amine compound, electrophotographic photoreceptor using the amine compound and image forming apparatus having the same
10/27/2005US20050238920 1,3,6,8-Tetrasubstituted pyrene compound, organic electroluminescent element, and organic electroluminescent display
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2562554A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005CA2562401A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/27/2005CA2561554A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/27/2005CA2560336A1 Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia
10/26/2005EP1589021A1 Process for producing 2-deoxyaldose compound
10/26/2005EP1589018A1 Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1589009A1 Vitamin d3 lactone derivative
10/26/2005EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587781A1 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289981A4 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688565A Method of obtaining citalopram
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688543A Furanone derivatives and methods of making same
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/26/2005CN1687050A Separation method for purifying gibberellin GA3
10/26/2005CN1687049A Sulfonated derivative of andrographolide and combination of medication
10/26/2005CN1687048A Ketones compound of hydrogenized diasporangiumsp, preparation method and application
10/26/2005CN1687047A Equipment and method for preparing crystal of vitamin C by fine crystal removing method
10/26/2005CN1687046A Method for preparing (S)-3-hydroxy group-gamma-butyrolactone
10/26/2005CN1687045A Catalysis method for synthesizing gamma butyrolactone
10/26/2005CN1224621C Tetrahydrofuran refining process
10/25/2005US6958404 Method for the hydrogenation of maleic anhydride and related compounds in a fluid bed reactor
10/25/2005US6958358 Inhibitors of cruzipain and other cysteine proteases
10/25/2005US6958219 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone
10/25/2005US6958145 Synthesis of cyclic compounds
1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 472